Here are five key points:
1. NuVasive reported the insider selling transaction on Dec. 14, 2016, to the Securities and Exchange Commission.
2. The shares were valued at $67.99 per share.
3. In a SEC Form 4 Filing, NuVasive reported the sold shares’ total value was $700,501.
4. On Dec. 12, NuVasive shares saw an intraday low of $67.11 and intraday high of $68.55.
5. The company’s shares closed at $67.45 on Dec. 12.
More articles on devices:
Zimmer Biomet’s growth strategy in spine: MIS, cervical and becoming a ‘health solutions provider’
Predictive Technology Group highlights US patent allowance for treating patients with genetic spinal deformities, syndromes: 5 highlights
Global wearable medical devices market to hit $12.1B by 2021: 9 observations
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
